HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 325-336 of 453
Other study type icon
RecruitingNCT07387705

On Track for Wellness (OTW) Stepped Wedge Cluster study

Official study title

On Track for Wellness: Stepped-wedge Cluster Randomized Trial of a Fitbit Enhanced Health Intervention for Early Onset Psychosis

In Chicago
SchizophreniaInterventional study
Countries
United States
Sponsor
University of Illinois Chicago
Drug study icon
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

Official study title

"Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: "Extended" Antipsychotic Dosing"

In Toronto
SchizophreniaMedication studyAges 18+
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
RecruitingNCT07369154

52-week Open Label Safety-Tolerability Study

What is this study about?

This study evaluates the safety of LB-102 for people with schizophrenia.

Multiple locations, including Chandler
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
LB Pharmaceuticals Inc.
Drug study icon
RecruitingNCT07615426

Aticaprant for schizophrenia

What is this study about?

This study evaluates the safety of Aticaprant for people with schizophrenia.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
Janssen Research & Development, LLC
Drug study icon
RecruitingNCT07424404

Xanomeline and Trospium Chloride for Schizophrenia

Official study title

A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride in Children and Adolescents With Psychiatric Disorders

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 5–17
Countries
United States, Australia, France, + 7 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Device study icon
RecruitingNCT05866107

App and Body Fat Scale in the Management of Overweight Patients

Official study title

Effectiveness and Feasibility of Self-Monitoring for Weight Management in Individuals With Mental Disorders Using Digital Intervention ("SWIM" Trial)

In Beijing
Schizophrenia, BipolarityDevice studyAges 18–60
Countries
China
Sponsor
Capital Medical University
Drug study icon
RecruitingNCT04113993

Bazedoxifene -Treatment for Women With Schizophrenia

Official study title

Bazedoxifene - A New Selective Estrogen Receptor Modulator Treatment for Women With Schizophrenia: a Double-blind, Randomized, Placebo Controlled Trial

In Melbourne
SchizophreniaMedication studyAges 18–65
Countries
Australia
Sponsor
The Alfred
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.